Patents by Inventor Shawn Pack

Shawn Pack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
    Publication number: 20070161790
    Abstract: The present invention provides novel processes and intermediates for preparing corticotropin releasing factor (CRF) receptor antagonists having the structure below which are useful in treating CRF-related disorders such as anxiety and depression.
    Type: Application
    Filed: March 13, 2007
    Publication date: July 12, 2007
    Inventors: James Sherbine, Shawn Pack, Jaan Pesti, Robert Yule, Kenneth McNulty
  • Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
    Publication number: 20060293304
    Abstract: A process is provided for preparing triazole substituted azaindoleoxoacetic piperazine derivative. Novel intermediates produced in the above process, and novel N-1 and amorphous forms of a 1,2,3-triazole substituted azaindoloxoacetic piperazine derivatives and processes for producing such novel forms are also provided.
    Type: Application
    Filed: June 19, 2006
    Publication date: December 28, 2006
    Inventors: Nachimuthu Soundararajan, Yuping Qiu, Wenhao Hu, David Kronenthal, Pierre Sirard, Jean Lajeunesse, Robert Droghini, Ramakrishnan Chidambaram, Xinhua Qian, Kenneth Natalie, Shawn Pack, Nathan Reising, Erqing Tang, Michael Fakes, Qi Gao, Feng Qian, Blisse Vakkalagadda, Chiajen Lai, Shan-Ming Kuang
  • Prodrugs of piperazine and substituted piperidine antiviral agents
    Publication number: 20050209246
    Abstract: This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. wherein: X is C or N with the proviso that when X is N, R1 does not exist; W is C or N with the proviso that when W is N, R2 does not exist; V is C; E is hydrogen or a pharmaceutically acceptable salt thereof; and Y is selected from the group consisting of Also, this invention provides for intermediate Compounds II useful in making prodrug Compounds I. wherein: L and M are independently selected from the group consisting of C1-C6 alkyl, phenyl, benzyl, trialkylsilyl, -2,2,2-trichloroethoxy and 2-trimethylsilylethoxy.
    Type: Application
    Filed: February 25, 2005
    Publication date: September 22, 2005
    Inventors: Yasutsugu Ueda, Timothy Connolly, John Kadow, Nicholas Meanwell, Tao Wang, Chung-Pin Chen, Kap-Sun Yeung, Zhongxing Zhang, David Leahy, Shawn Pack, Nachimuthu Soundararajan, Pierre Sirard, Kathia Levesque, Dominique Thoraval
  • Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
    Publication number: 20050143380
    Abstract: The present invention provides novel processes and intermediates for preparing corticotropin releasing factor (CRF) receptor antagonists having the structure below which are useful in treating CRF-related disorders such as anxiety and depression.
    Type: Application
    Filed: November 10, 2004
    Publication date: June 30, 2005
    Inventors: James Sherbine, Shawn Pack, Jaan Pesti, Robert Yule, Kenneth McNulty